285 related articles for article (PubMed ID: 16646575)
1. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.
García-Martín E; Martínez C; Ladero JM; Agúndez JA
Mol Diagn Ther; 2006; 10(1):29-40. PubMed ID: 16646575
[TBL] [Abstract][Full Text] [Related]
2. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
Kudzi W; Dodoo AN; Mills JJ
BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
Kirchheiner J; Roots I; Goldammer M; Rosenkranz B; Brockmöller J
Clin Pharmacokinet; 2005; 44(12):1209-25. PubMed ID: 16372821
[TBL] [Abstract][Full Text] [Related]
6. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms.
García-Martín E
Curr Drug Metab; 2008 Jul; 9(6):487-97. PubMed ID: 18680468
[TBL] [Abstract][Full Text] [Related]
7. The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.
Martínez C; García-Martín E; Blanco G; Gamito FJ; Ladero JM; Agúndez JA
Br J Clin Pharmacol; 2005 Jan; 59(1):62-9. PubMed ID: 15606441
[TBL] [Abstract][Full Text] [Related]
8. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
[TBL] [Abstract][Full Text] [Related]
9. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
[TBL] [Abstract][Full Text] [Related]
10. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study.
Vicente J; González-Andrade F; Soriano A; Fanlo A; Martínez-Jarreta B; Sinués B
Mol Biol Rep; 2014 Mar; 41(3):1267-72. PubMed ID: 24430292
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
[TBL] [Abstract][Full Text] [Related]
13. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
[TBL] [Abstract][Full Text] [Related]
14. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
Zand N; Tajik N; Moghaddam AS; Milanian I
Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743
[TBL] [Abstract][Full Text] [Related]
16. Global variation in CYP2C8-CYP2C9 functional haplotypes.
Speed WC; Kang SP; Tuck DP; Harris LN; Kidd KK
Pharmacogenomics J; 2009 Aug; 9(4):283-90. PubMed ID: 19381162
[TBL] [Abstract][Full Text] [Related]
17. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
[TBL] [Abstract][Full Text] [Related]
18. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
López-Rodríguez R; Novalbos J; Gallego-Sandín S; Román-Martínez M; Torrado J; Gisbert JP; Abad-Santos F
Pharmacol Res; 2008 Jul; 58(1):77-84. PubMed ID: 18694831
[TBL] [Abstract][Full Text] [Related]
19. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of CYP2C8 polymorphisms in a North Indian population.
Minhas S; Setia N; Pandita S; Saxena R; Verma IC; Aggarwal S
Genet Mol Res; 2013 Jul; 12(3):2260-6. PubMed ID: 23884769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
